My Quote Request
6505-01-130-3329
20 Products
NDC00008-0006-06
OXAZEPAM CAPSULES,USP
NSN, MFG P/N
6505011303329
NSN
6505-01-130-3329
NDC00008-0006-06
OXAZEPAM CAPSULES,USP
NSN, MFG P/N
6505011303329
NSN
6505-01-130-3329
MFG
AMERICAN HOME PRODUCTS CORP WYETH-AYERST LABORATORIES DIV
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 15.000 MILLIGRAMS OXAZEPAM ACTIVE INGREDIENT
CAPSULE CONTENT FORM: ANY ACCEPTABLE
CAPSULE PRIMARY CONTAINER CONTENT QUANTITY: 100.000
CAPSULE TYPE: ANY ACCEPTABLE
FEATURES PROVIDED: INDIVIDUALLY SEALED
PRIMARY CONTAINER TYPE: CARTON
SPECIAL FEATURES: CONTROLLED SUBSTANCE CLASSIFICATION:SCHEDULE IV
Related Searches:
NDC16837-0630-03
SIMETHICONE ORAL SUSPENSION,USP
NSN, MFG P/N
6505011289480
NSN
6505-01-128-9480
NDC16837-0630-03
SIMETHICONE ORAL SUSPENSION,USP
NSN, MFG P/N
6505011289480
NSN
6505-01-128-9480
MFG
JOHNSON AND JOHNSON/MERCK PHARMACEUTICALS CO A JOINT VENTURE
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 40 MG SIMETHICONE PER 0.6 ML
III PART NAME ASSIGNED BY CONTROLLING AGENCY: SIMETHICONE ORAL SUSPENSION USP 40MG/0.6ML 30ML BT 12S
PRIMARY CONTAINER CONTENT QUANTITY: 30.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE, DROPPER
SPECIAL FEATURES: SCREW CAP DROPPER
TOTAL PRIMARY CONTAINER QUANTITY: 12
Related Searches:
NDC00121-0458-15
DOCUSATE SODIUM AND CASANTHRANOL SYRUP
NSN, MFG P/N
6505011289914
NSN
6505-01-128-9914
NDC00121-0458-15
DOCUSATE SODIUM AND CASANTHRANOL SYRUP
NSN, MFG P/N
6505011289914
NSN
6505-01-128-9914
MFG
PHARMACEUTICAL ASSOCIATES INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 30.000 MILLIGRAMS CASANTHRANOL ACTIVE INGREDIENT AND 60.000 MILLIGRAMS DOCUSATE SODIUM ACTIVE INGREDIENT
PRIMARY CONTAINER CONTENT QUANTITY: 15.000 MILLILITERS
PRIMARY CONTAINER TYPE: CUP
TOTAL PRIMARY CONTAINER QUANTITY: 100
Related Searches:
NDC65473-0718-01
TRIMIPRAMINE MALEATE CAPSULES
NSN, MFG P/N
6505011291746
NSN
6505-01-129-1746
NDC65473-0718-01
TRIMIPRAMINE MALEATE CAPSULES
NSN, MFG P/N
6505011291746
NSN
6505-01-129-1746
MFG
ODYSSEY PHARMACEUTICALS INC DBA FOREIGN PARENT IS PLIVA DD CROATIA.
Description
CAPSULE CONTENT FORM: ANY ACCEPTABLE
CAPSULE PRIMARY CONTAINER CONTENT QUANTITY: 100.000
CAPSULE TYPE: ANY ACCEPTABLE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: TRIMIPRAMINE MALEATE CAPSULES 25MG 100S BT
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: 25 MG TRIMIPRAMINE MALEATE
Related Searches:
NDC65473-0719-01
TRIMIPRAMINE MALEATE CAPSULES
NSN, MFG P/N
6505011291747
NSN
6505-01-129-1747
NDC65473-0719-01
TRIMIPRAMINE MALEATE CAPSULES
NSN, MFG P/N
6505011291747
NSN
6505-01-129-1747
MFG
ODYSSEY PHARMACEUTICALS INC DBA FOREIGN PARENT IS PLIVA DD CROATIA.
Description
CAPSULE CONTENT FORM: ANY ACCEPTABLE
CAPSULE PRIMARY CONTAINER CONTENT QUANTITY: 100.000
CAPSULE TYPE: ANY ACCEPTABLE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: TRIMIPRAMINE MALEATE CAPSULES 50MG 100S BT
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: 50 MG TRIMIPRAMINE MALEATE
Related Searches:
NDC00078-0098-15
TEMAZEPAM CAPSULES
NSN, MFG P/N
6505011291748
NSN
6505-01-129-1748
MFG
NOVARTIS PHARMACEUTICALS CORPORATION
Description
ADMINISTRATION: ORAL
CAPSULE CONTENT FORM: ANY ACCEPTABLE
CAPSULE PRIMARY CONTAINER CONTENT QUANTITY: 30.000
CAPSULE TYPE: ANY ACCEPTABLE
FEATURES PROVIDED: CHILD RESISTANT CLOSURE
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: 15 MG PER CAPSULE; WITH THREE PART LABEL
Related Searches:
NDC00078-0099-15
TEMAZEPAM CAPSULES
NSN, MFG P/N
6505011291749
NSN
6505-01-129-1749
MFG
NOVARTIS PHARMACEUTICALS CORPORATION
Description
ADMINISTRATION: ORAL
CAPSULE CONTENT FORM: ANY ACCEPTABLE
CAPSULE PRIMARY CONTAINER CONTENT QUANTITY: 30.000
CAPSULE TYPE: ANY ACCEPTABLE
FEATURES PROVIDED: CHILD RESISTANT CLOSURE
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: 30 MG PER CAPSULE; WITH THREE PART LABEL
Related Searches:
11365
FC BROTH
NSN, MFG P/N
6505011295783
NSN
6505-01-129-5783
MFG
BECTON-DICKINSON AND CO MICROBIOLOGY SYSTEMS DIV
Description
FC BROTH
Related Searches:
11369
STANDARDS METHOD BR
NSN, MFG P/N
6505011295784
NSN
6505-01-129-5784
MFG
BECTON-DICKINSON AND CO MICROBIOLOGY SYSTEMS DIV
Description
STANDARDS METHOD BR
Related Searches:
11694
TECH AGAR
NSN, MFG P/N
6505011295785
NSN
6505-01-129-5785
MFG
BECTON-DICKINSON AND CO MICROBIOLOGY SYSTEMS DIV
Description
TECH AGAR
Related Searches:
11430
MOELLER DECARBOXYLA
NSN, MFG P/N
6505011295786
NSN
6505-01-129-5786
MFG
BECTON-DICKINSON AND CO MICROBIOLOGY SYSTEMS DIV
Description
MOELLER DECARBOXYLA
Related Searches:
NDC00071-0204-40
PROCAINAMIDE HYDROCHLORIDE EXTENDED-RELEASE TABLETS,USP
NSN, MFG P/N
6505011301298
NSN
6505-01-130-1298
NDC00071-0204-40
PROCAINAMIDE HYDROCHLORIDE EXTENDED-RELEASE TABLETS,USP
NSN, MFG P/N
6505011301298
NSN
6505-01-130-1298
MFG
PARKE-DAVIS DIV OF WARNER-LAMBERT CO
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 500.000 MILLIGRAMS PROCAINAMIDE HYDROCHLORIDE ACTIVE INGREDIENT
FEATURES PROVIDED: INDIVIDUALLY SEALED
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: STRIP
THERAPEUTIC EQUIVALENT: PROCAN SR BY PARKE-DAVIS
Related Searches:
PROCAN SR
PROCAINAMIDE HYDROCHLORIDE EXTENDED-RELEASE TABLETS,USP
NSN, MFG P/N
6505011301298
NSN
6505-01-130-1298
PROCAN SR
PROCAINAMIDE HYDROCHLORIDE EXTENDED-RELEASE TABLETS,USP
NSN, MFG P/N
6505011301298
NSN
6505-01-130-1298
MFG
PARKE-DAVIS DIV OF WARNER-LAMBERT CO
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 500.000 MILLIGRAMS PROCAINAMIDE HYDROCHLORIDE ACTIVE INGREDIENT
FEATURES PROVIDED: INDIVIDUALLY SEALED
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: STRIP
THERAPEUTIC EQUIVALENT: PROCAN SR BY PARKE-DAVIS
Related Searches:
NDC00056-0205-16
AMANTADINE HYDROCHLORIDE SYRUP,USP
NSN, MFG P/N
6505011301945
NSN
6505-01-130-1945
NDC00056-0205-16
AMANTADINE HYDROCHLORIDE SYRUP,USP
NSN, MFG P/N
6505011301945
NSN
6505-01-130-1945
MFG
BRISTOL-MYERS SQUIBB PHARMA COMPANY
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 50.000 MILLIGRAMS AMANTADINE HYDROCHLORIDE PER 5 MILLILITERS
FLAVOR: ANY ACCEPTABLE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: AMANTADINE HYDROCHLORIDE SYRUP USP 10MG/ML 1PT OR 473ML BT
PRIMARY CONTAINER CONTENT QUANTITY: 480.000 MILLILITERS OR 16.000 FLUID OUNCES
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
NDC00121-0646-16
AMANTADINE HYDROCHLORIDE SYRUP,USP
NSN, MFG P/N
6505011301945
NSN
6505-01-130-1945
NDC00121-0646-16
AMANTADINE HYDROCHLORIDE SYRUP,USP
NSN, MFG P/N
6505011301945
NSN
6505-01-130-1945
MFG
PHARMACEUTICAL ASSOCIATES INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 50.000 MILLIGRAMS AMANTADINE HYDROCHLORIDE PER 5 MILLILITERS
FLAVOR: ANY ACCEPTABLE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: AMANTADINE HYDROCHLORIDE SYRUP USP 10MG/ML 1PT OR 473ML BT
PRIMARY CONTAINER CONTENT QUANTITY: 480.000 MILLILITERS OR 16.000 FLUID OUNCES
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
NDC00603-1010-58
AMANTADINE HYDROCHLORIDE SYRUP,USP
NSN, MFG P/N
6505011301945
NSN
6505-01-130-1945
NDC00603-1010-58
AMANTADINE HYDROCHLORIDE SYRUP,USP
NSN, MFG P/N
6505011301945
NSN
6505-01-130-1945
MFG
GENERICS BIDCO I LLC DBA QUALITEST PHARMACEUTICALS
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 50.000 MILLIGRAMS AMANTADINE HYDROCHLORIDE PER 5 MILLILITERS
FLAVOR: ANY ACCEPTABLE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: AMANTADINE HYDROCHLORIDE SYRUP USP 10MG/ML 1PT OR 473ML BT
PRIMARY CONTAINER CONTENT QUANTITY: 480.000 MILLILITERS OR 16.000 FLUID OUNCES
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
NDC63481-0205-16
AMANTADINE HYDROCHLORIDE SYRUP,USP
NSN, MFG P/N
6505011301945
NSN
6505-01-130-1945
NDC63481-0205-16
AMANTADINE HYDROCHLORIDE SYRUP,USP
NSN, MFG P/N
6505011301945
NSN
6505-01-130-1945
MFG
ENDO PHARMACEUTICALS INC.
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 50.000 MILLIGRAMS AMANTADINE HYDROCHLORIDE PER 5 MILLILITERS
FLAVOR: ANY ACCEPTABLE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: AMANTADINE HYDROCHLORIDE SYRUP USP 10MG/ML 1PT OR 473ML BT
PRIMARY CONTAINER CONTENT QUANTITY: 480.000 MILLILITERS OR 16.000 FLUID OUNCES
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
CARMOL-HC
HYDROCORTISONE ACETATE AND UREA CREAM
NSN, MFG P/N
6505011303318
NSN
6505-01-130-3318
CARMOL-HC
HYDROCORTISONE ACETATE AND UREA CREAM
NSN, MFG P/N
6505011303318
NSN
6505-01-130-3318
MFG
SYNTEX LABORATORIES INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 1.000 PERCENTAGE, W/V HYDROCORTISONE ACETATE ACTIVE INGREDIENT AND 10.000 PERCENTAGE, W/V UREA ACTIVE INGREDIENT
ADMINISTRATION: TOPICAL
PRIMARY CONTAINER CONTENT QUANTITY: 4.000 OUNCES
PRIMARY CONTAINER TYPE: JAR
Related Searches:
NDC00033-2550-11
HYDROCORTISONE ACETATE AND UREA CREAM
NSN, MFG P/N
6505011303318
NSN
6505-01-130-3318
NDC00033-2550-11
HYDROCORTISONE ACETATE AND UREA CREAM
NSN, MFG P/N
6505011303318
NSN
6505-01-130-3318
MFG
SYNTEX LABORATORIES INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 1.000 PERCENTAGE, W/V HYDROCORTISONE ACETATE ACTIVE INGREDIENT AND 10.000 PERCENTAGE, W/V UREA ACTIVE INGREDIENT
ADMINISTRATION: TOPICAL
PRIMARY CONTAINER CONTENT QUANTITY: 4.000 OUNCES
PRIMARY CONTAINER TYPE: JAR
Related Searches:
F008000606
OXAZEPAM CAPSULES,USP
NSN, MFG P/N
6505011303329
NSN
6505-01-130-3329
MFG
DEFENSE LOGISTICS AGENCY DIRECTORATE OF MEDICAL MATERIEL DEFENSE SUPPLY CENTER PHILADELPHIA
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 15.000 MILLIGRAMS OXAZEPAM ACTIVE INGREDIENT
CAPSULE CONTENT FORM: ANY ACCEPTABLE
CAPSULE PRIMARY CONTAINER CONTENT QUANTITY: 100.000
CAPSULE TYPE: ANY ACCEPTABLE
FEATURES PROVIDED: INDIVIDUALLY SEALED
PRIMARY CONTAINER TYPE: CARTON
SPECIAL FEATURES: CONTROLLED SUBSTANCE CLASSIFICATION:SCHEDULE IV